Wyeth Pharmaceuticals Ltd. would like to inform you of their intention to discontinue the marketing of Trinordiol tablets. Trinordiol tablets will be discontinued when current stock is exhausted. Wyeth regrets any inconvenience this discontinuation may cause. Please do not hesitate to contact their Medical Department at (01) 4493500 should you require any further information.

AstraZeneca regrets to inform you that due to a recent manufacturing issue, supplies of Xylocaine 4% w/v Topical Mucosal Solution will be in short supply over the coming weeks and are likely to be fully depleted within 5 to 6 weeks, based on current demand. Xylocaine Pump Spray 10% is not affected by this issue. [...]